33 min listen
MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis
MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis
ratings:
Length:
44 minutes
Released:
Oct 6, 2022
Format:
Podcast episode
Description
Moderators Aravind M Menon, MD, MPH, and Alice Gallo de Moraes, MD, and journal CHEST® author Sahajal Dhooria, MD, DM, discuss the article, "MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis," which was published in the October issue.
DOI: https://doi.org/10.1016/j.chest.2022.04.001
DOI: https://doi.org/10.1016/j.chest.2022.04.001
Released:
Oct 6, 2022
Format:
Podcast episode
Titles in the series (100)
Modifying Criteria For Systemic Inflammatory Response Syndrome To Improve Its Predictive Value: Simon J. Finney, PhD, MBChB, editiorialist Arthur P. Wheeler, MD, FCCP, and CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, discuss an article by Dr. Finney and others that reviews their research into modifying the traditional definition of the systemic... by CHEST Journal Podcasts